首页> 外文期刊>Investigational new drugs. >Identification of differentially expressed genes and signaling pathways using bioinformatics in interstitial lung disease due to tyrosine kinase inhibitors targeting the epidermal growth factor receptor
【24h】

Identification of differentially expressed genes and signaling pathways using bioinformatics in interstitial lung disease due to tyrosine kinase inhibitors targeting the epidermal growth factor receptor

机译:靶向表皮生长因子受体的酪氨酸激酶抑制剂,在间质肺病中使用生物信息学鉴定差异表达基因和信号通路

获取原文
获取原文并翻译 | 示例
           

摘要

Interstitial lung disease (ILD) is a rare but lethal adverse effect of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) treatment. The specific mechanism of this disease is not fully understood. To systematically analyze genes associated with EGFR-TKI induced ILD, gene data of EGFR-TKI induced ILD were extracted initially using text mining, and then the intersection between genes from text mining and Gene Expression Omnibus (GEO) dataset was taken for further protein-protein interaction (PPI) analysis using String-bd database. Go ontology (GO) and pathway enrichment analysis was also conducted based on Database of Annotation, Visualization and Integrated Discovery (DAVID) platform. The PPI network generated by STRING was visualized by Cytoscape, and the topology scores, functional regions and gene annotations were analyzed using plugins of CytoNCA, molecular complex detection (MCODE) and ClueGo. 37 genes were identified as EGFR-TKI induced ILD related. Gene enrichment analysis yield 18 enriched GO terms and 12 associated pathways. A PPI network that included 199 interactions for a total of 35 genes was constructed. Ten genes were selected as hub genes using CytoNCA plugin, and four highly connected clusters were identified using MCODE plugin. GO and pathway annotation analysis for the cluster one revealed that five genes were associated with either response to dexamethasone or with lung fibrosis, including CTGF, CCL2, IGF1, EGFR and ICAM1. Our data might be useful to reveal the pathological mechanisms of EGFR-TKI induced ILD and provide evidence for the diagnosis and treatment in the future.
机译:间质肺病(ILD)是表皮生长因子受体(EGFR)酪氨酸激酶抑制剂(TKIS)治疗的罕见但致死的不良影响。该疾病的特定机制尚未完全理解。为了系统地分析与EGFR-TKI诱导的ILD相关的基因,最初使用文本挖掘提取EGFR-TKI诱导的ILD的基因数据,然后从文本挖掘和基因表达综合(GEO)数据集之间的基因之间的交叉进行进一步的蛋白质 - 使用String-BD数据库进行蛋白质相互作用(PPI)分析。还基于注释,可视化和集成发现(DAVID)平台数据库进行了本体(GO)和途径浓缩分析。通过Cytoscape可视化串生成的PPI网络,使用骨盆,分子复数(MCODE)和Clufo的插件分析拓扑分数,功能区和基因注释。将37个基因鉴定为EGFR-TKI诱导的ILD相关。基因富集分析产量18富阶段和12个相关途径。构建了包括199个基因的199个相互作用的PPI网络。选择10个基因作为使用骨盆插件的轮毂基因,并使用MCODE插件识别出四个高度连接的簇。群体的GO和途径注释分析显示,五种基因与对地塞米松或肺纤维化的反应相关,包括CTGF,CCL2,IGF1,EGFR和ICAM1。我们的数据可能有助于揭示EGFR-TKI诱导ILD的病理机制,并为未来的诊断和治疗提供证据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号